Mesothelin-targeted CAR T-cell therapy shows early promise in patients with solid tumors
A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity and had […]
A team of researchers including investigators from Mayo Clinic has identified a technology to address the problem of false positives […]Mesothelioma
Method to overcome false positives in CT imaging for lung cancer